Joseph Stringer
Stock Analyst at Needham
(4.52)
# 334
Out of 4,496 analysts
219
Total ratings
57.55%
Success rate
17.83%
Average return
Main Sectors:
Top Industries:
20 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals | Reiterates: Buy | $26 | $10.95 | +137.55% | 37 | Jul 19, 2024 | |
| PLRX Pliant Therapeutics | Reiterates: Buy | $38 | $12.36 | +207.44% | 13 | Jul 16, 2024 | |
| MRNA Moderna | Reiterates: Hold | n/a | $121.14 | - | 5 | Jun 28, 2024 | |
| PCVX Vaxcyte | Reiterates: Buy | $95 | $81.63 | +16.38% | 9 | Jun 28, 2024 | |
| STOK Stoke Therapeutics | Reiterates: Buy | $22 | $13.58 | +62.00% | 14 | Jun 28, 2024 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $200 → $275 | $237.83 | +15.63% | 13 | Jun 24, 2024 | |
| CARA Cara Therapeutics | Downgrades: Hold | n/a | $0.34 | - | 15 | Jun 13, 2024 | |
| RNA Avidity Biosciences | Maintains: Buy | $35 → $46 | $45.12 | +1.95% | 12 | Jun 12, 2024 | |
| VIR Vir Biotechnology | Maintains: Buy | $15 → $19 | $10.03 | +89.43% | 13 | Jun 5, 2024 | |
| ANNX Annexon | Reiterates: Buy | $16 | $5.63 | +184.19% | 15 | Jun 4, 2024 | |
| IONS Ionis Pharmaceuticals | Reiterates: Buy | $60 | $47.82 | +25.47% | 13 | Jun 3, 2024 | |
| CDTX Cidara Therapeutics | Reiterates: Buy | $25 | $11.81 | +111.69% | 7 | May 16, 2024 | |
| INZY Inozyme Pharma | Reiterates: Buy | $23 | $5.33 | +331.52% | 13 | May 8, 2024 | |
| APLS Apellis Pharmaceuticals | Reiterates: Buy | $85 | $37.98 | +123.80% | 14 | May 8, 2024 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $50 → $46 | $49.57 | -7.20% | 14 | May 7, 2024 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Hold | n/a | $491.57 | - | 1 | May 7, 2024 | |
| LXRX Lexicon Pharmaceuticals | Reiterates: Hold | n/a | $1.99 | - | 4 | May 3, 2024 | |
| GILD Gilead Sciences | Reiterates: Hold | n/a | $72.56 | - | 1 | Apr 26, 2024 | |
| ACAD ACADIA Pharmaceuticals | Upgrades: Buy | $37 | $17.75 | +108.45% | 4 | Jan 24, 2024 | |
| TBPH Theravance Biopharma | Maintains: Buy | n/a | $9.57 | - | 2 | Aug 24, 2021 |
Phathom Pharmaceuticals
Jul 19, 2024
Reiterates: Buy
Price Target: $26
Current: $10.95
Upside: +137.55%
Pliant Therapeutics
Jul 16, 2024
Reiterates: Buy
Price Target: $38
Current: $12.36
Upside: +207.44%
Moderna
Jun 28, 2024
Reiterates: Hold
Price Target: n/a
Current: $121.14
Upside: -
Vaxcyte
Jun 28, 2024
Reiterates: Buy
Price Target: $95
Current: $81.63
Upside: +16.38%
Stoke Therapeutics
Jun 28, 2024
Reiterates: Buy
Price Target: $22
Current: $13.58
Upside: +62.00%
Alnylam Pharmaceuticals
Jun 24, 2024
Maintains: Buy
Price Target: $200 → $275
Current: $237.83
Upside: +15.63%
Cara Therapeutics
Jun 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.34
Upside: -
Avidity Biosciences
Jun 12, 2024
Maintains: Buy
Price Target: $35 → $46
Current: $45.12
Upside: +1.95%
Vir Biotechnology
Jun 5, 2024
Maintains: Buy
Price Target: $15 → $19
Current: $10.03
Upside: +89.43%
Annexon
Jun 4, 2024
Reiterates: Buy
Price Target: $16
Current: $5.63
Upside: +184.19%
Ionis Pharmaceuticals
Jun 3, 2024
Reiterates: Buy
Price Target: $60
Current: $47.82
Upside: +25.47%
Cidara Therapeutics
May 16, 2024
Reiterates: Buy
Price Target: $25
Current: $11.81
Upside: +111.69%
Inozyme Pharma
May 8, 2024
Reiterates: Buy
Price Target: $23
Current: $5.33
Upside: +331.52%
Apellis Pharmaceuticals
May 8, 2024
Reiterates: Buy
Price Target: $85
Current: $37.98
Upside: +123.80%
Rhythm Pharmaceuticals
May 7, 2024
Maintains: Buy
Price Target: $50 → $46
Current: $49.57
Upside: -7.20%
Vertex Pharmaceuticals
May 7, 2024
Reiterates: Hold
Price Target: n/a
Current: $491.57
Upside: -
Lexicon Pharmaceuticals
May 3, 2024
Reiterates: Hold
Price Target: n/a
Current: $1.99
Upside: -
Gilead Sciences
Apr 26, 2024
Reiterates: Hold
Price Target: n/a
Current: $72.56
Upside: -
ACADIA Pharmaceuticals
Jan 24, 2024
Upgrades: Buy
Price Target: $37
Current: $17.75
Upside: +108.45%
Theravance Biopharma
Aug 24, 2021
Maintains: Buy
Price Target: n/a
Current: $9.57
Upside: -